about
Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature.Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases.A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.Advances in immunosuppression for renal transplantation.Complement modulation in solid-organ transplantation.Renal involvement in primary Sjögren syndrome.Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.Rituximab in anti-GBM disease: A retrospective study of 8 patients.Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management.Role for thromboxane receptors in angiotensin-II-induced hypertension.Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.Intracellular lactate flux: a new regulator of the allogenic immune response.Renal fibrosis: Recent translational aspects.The role of cannabinoid receptors in renal diseases.Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study.SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation.Preoperative Risk Factors Associated With Urinary Complications After Kidney Transplantation.The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.Maturity onset diabetes of the young: clinical characteristics and outcome after kidney and pancreas transplantation in MODY3 and RCAD patients: a single center experience.[The Script Concordance Test: A multimodal teaching tool].IgG4-related disease associated with renal microaneurysms and polycythaemia.Comparison of the AN69ST Membrane versus Citrate-Enriched Dialysate on Clotting Events during Hemodialysis without Systemic Anticoagulation.Cannabinoid receptor 1 is a major mediator of renal fibrosis.[An unusual kidney lesion in a renal transplant].[Use of new non-nephrotoxic immunosuppressive drugs in kidney transplantation, especially after ischemia-reperfusion injury].Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases[A rare cause of renal graft dysfunction]Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations[History of medical progress in renal transplantation: a review of 3,000 consecutive kidney grafts at Bicetre-Kremlin, Bicetre University Hospital - France]IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapyEfficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patientsNon-tolerability of double-filtration plasmapheresis in antibody-incompatible kidney transplant candidates[Role of cannabinoid receptors in renal diseases]Effect of a proteasome inhibitor plus steroids on HLA antibodies in sensitized patients awaiting a renal transplant
P50
Q26826085-C2D1B2C3-B763-4657-8B4A-E90D8AF864EBQ33821866-44AA827F-348F-4866-A7AA-F23F2660E1B3Q34171181-7010DA3B-5F03-4F49-89B0-287B1DABBAA0Q36150869-2C760527-F907-4DAC-AEFF-7A1CD2D6E042Q36219673-17609327-7D34-4E9B-AF47-BA3094E7F763Q37586853-4ABB10EA-F04E-4E2E-9B6E-B6C1C11A4A68Q37686066-60B2CB76-9804-433D-940B-DF42331FE5A9Q38226479-7074BFB6-99BF-4C7B-81AB-E06D79998BD1Q38633492-33047E39-CE41-40C5-A4A7-31FCF6F8A545Q40241924-84C81242-CAED-47E7-A964-D40F41CD38C6Q40962483-FA6CF139-B6BB-41DA-A341-CFFB2981BB70Q41488993-067D4C18-D608-4F3D-8F7A-D1778255D6B0Q41651902-A54D5CCF-1715-47B1-8C7D-ED53835EDF2CQ44560747-7A3142B0-05D7-4811-B582-100FD85BDD1BQ44725166-B4699DA1-9D1C-4BBD-8A6D-07E12554DEC8Q45766918-61869296-35B9-43F5-8E79-9DD5357C999BQ46269231-62C893A8-33B5-4325-9510-654A2AF36CE1Q47239851-58E7AE2B-2F65-4369-AB84-A9F4210790FDQ47812500-CA73FBF5-4304-4972-A993-1D67A9A6F670Q47927447-726411F0-5F2F-46BF-B5D5-FF059DA63B96Q49868718-6F79C04E-1C26-482D-851F-D60C94CBC40DQ49917239-7BCD8C03-188E-48FD-A154-070F994BA80CQ50961285-9DB1C7FF-D1CC-421B-8807-8F920DBF008AQ51359429-C0929DA7-3BAB-43DA-8412-52A64C9BDBD6Q52632987-71805FBF-A3AE-424C-8092-3FE87C7EDB9BQ52990288-221832D0-69A7-4918-8981-2DEE7F2136D8Q53519014-004AF150-744C-43F0-AD97-F5794AA63EEDQ53587541-F3C1D236-B6F7-48D4-A69C-B0310CF66E56Q54386389-F2F05C30-BBDC-4445-8D11-AF0D9195353BQ54526449-38A0E0A2-0CCA-4A7B-AB74-219B6069CCE0Q59336403-477F0839-3B60-4883-953E-C39EA6D729E4Q64379725-1BF4B4F2-9E4D-4BDD-BDE8-65F5B659B816Q79447721-820212DF-F3D8-41EB-9640-0E3A9770684EQ82572899-17C7E582-7532-457A-8525-15A53B661C73Q84128624-996681F7-412F-4337-B87F-306935873C52Q84776805-4E45198D-9B75-4FEF-9C57-7ACE0B5E4E16Q86902117-8B334B13-850D-4604-B48C-518A0363F8A8Q87444228-DF346854-CF37-4104-9000-53A1E64112CEQ87740160-0E664F31-B03B-4B1C-9C76-548A343E88D5
P50
description
researcher
@en
name
Hélène François
@en
Hélène François
@nl
type
label
Hélène François
@en
Hélène François
@nl
prefLabel
Hélène François
@en
Hélène François
@nl
P106
P31
P496
0000-0001-7436-9554